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Background: Tuberculous lymphadenitis is next to pulmonary tuberculosis as the most common cause of tuberculosis.
Uganda genotype, one of the sub-lineages of Mycobacterium tuberculosis, is the most prevalent cause of pulmonary
tuberculosis in Uganda. We here investigate the clinicopathological characteristics of patients with tuberculous
lymphadenitis infected with M. tuberculosis Uganda genotype compared with those infected with M. tuberculosis
non-Uganda genotype strains.
Methods: Between 2010 and 2012, we enrolled 121 patients (mean age 28.5 yrs, male 48%; female 52%) with
tuberculous lymphadenitis, and categorized them by their M. tuberculosis genotypes. The clinical features and lymph
node cytopathological parameters were compared between patients in the Uganda and non-Uganda categories using a
crude and multivariable logistic regression model with adjustment for confounding factors.
Results: Of the 121participants, 56 (46%) were infected with strains of Uganda genotype. Patients infected with this
genotype had significantly lower frequency of abdominal lymphadenopathy (odds ratio 0.4, p = 0.046) after adjusting for
sex, age and HIV. Abdominal lymphadenopathy was also significantly associated with abnormal chest X-ray (p = 0.027).
Conclusion: Tuberculous lymphadenitis patients infected with M. tuberculosis Uganda genotype were significantly less
prone to have abdominal lymphadenopathy indicating potential reduced ability to disseminate and supporting the
concept that differences in M. tuberculosis genotype may have clinical implications.
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Tuberculosis (TB) remains a major global health prob-
lem. The latest estimates by WHO reveal that there were
almost 8.6 million new cases in 2012 and 1.3 million TB
deaths, 980 000 among HIV negative people and 320
000 HIV-associated TB deaths [1]. Uganda is ranked
16th among the 22 high burden countries with preva-
lence of 175 cases per 100,000 in 2012 of all forms of
TB [2], and 60% of the patients are co-infected with* Correspondence: dwamala@gmail.com
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reproduction in any medium, provided the orHIV. The HIV prevalence in the Ugandan adult popula-
tion is 6.7% [3].
Various host determinants such as sex, age and HIV co-
infection influence the development of TB [4,5], and the
clinical outcome of Mycobacterium tuberculosis infection
has been mainly attributed to host factors [6-9]. However,
there is a broad variation in clinical pathological manifesta-
tions of TB in both HIV positive and HIV negative patients,
which cannot be explained exclusively by host or environ-
mental factors. Autopsy observations in Mulago Hospital,
Kampala, have revealed severe or disseminated TB in HIV
negative cases (unpublished information).
M. tuberculosis has evolved into a number of widely
distributed and genetically diverse lineages and sub-lineages
[10] exhibiting variable disease phenotypic characteristicsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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models [11,12]. This together with diversity of the host im-
munological response may explain the wide clinical-
immunopathological spectrum of disease in those patients
who cannot control the infection [13].
M. tuberculosis Uganda genotype causes up to 70% of
pulmonary TB in Kampala [14], and other districts of
Uganda [15,16]. The Uganda genotype as cause of other
disease manifestations has however not been studied. Al-
though TB is mainly a pulmonary disease, M. tuberculosis
can infect any part of the body. Extrapulmonary TB
(EPTB) has been reported in 15–20% of HIV-negative pa-
tients [17,18], and the proportion is much higher in pa-
tients infected with HIV [17-19]. EPTB is thought to be
caused by spread of bacteria by the haematogenous route
from an initial focus in the lung and as such to represent a
disseminated form of TB disease [20]. The commonest
manifestation of EPTB is in most settings peripheral
lymphadenitis [19,21,22].
The aim of this study was to assess the clinico-
pathological features of TB in patients with peripheral
TB lymphadenitis and to determine whether those in-
fected with strains of Uganda genotype display specific
clinical, radiological and cytopathological features com-




Ethical approval for the study was granted by the Institu-
tional Review Board of Makerere University School of
Medicine and the Uganda National Council for Science
and Technology. Written informed consent to obtain
samples as well as to use isolates from the samples for
studies was obtained from all enrolled study participants
or their legal guardians.
Study population
This was a cross sectional study conducted between
February 2010 and July 2012, at the fine needle aspiration
clinic, Mulago Teaching and National Referral Hospital,
Kampala and Department of Medical Microbiology, Makerere
University College of Health Sciences. Patients with per-
sistent lymphadenopathy at this hospital are routinely re-
ferred from medical or surgical units. In this study, 283
ethnic African patients with superficial lymphadenopathy
and evening fever were enrolled.
Patients presenting with superficial persistent lymph node
enlargement, and cytological and clinical features of TB
were recruited into the study after written informed con-
sent. The clinical features of TB included unintentional
weight loss, fatigue, night sweats, evening fevers for more
than 4 weeks and loss of appetite. Tuberculous lymphaden-
itis was defined based on: i) superficial lymphadenopathyequal to or greater than 1x1cm persistent for more than
4 weeks. ii) cytological features consistent with TB and iii)
culture of lymph node aspirate positive for M. tuberculosis
complex bacteria with or without prior Ziehl Neelsen (ZN)
or Auramine acid fast bacilli (AFB) positive smear. The pa-
tients were anti-tuberculous drug naive and had failed to
respond to conventional antibiotics. Participants who con-
sented to HIV testing were screened for antibodies against
HIV 1 and HIV 2 by enzyme-linked immunosorbent assay
(ELISA) after pre-test counseling. Patients were excluded if
they had a neoplastic condition, culture negative lymph
node aspirates or did not consent to fine needle aspiration
(FNA).
After capturing the demographic data such as age, sex
and HIV status, the participants’ relevant clinical history
suggestive of TB was recorded. They were examined and
in particular assessed for clinical, radiological and patho-
logical parameters including lymph node site, size and
consistence.
Abdominal ultrasound scans were performed to look
for abnormal findings suggestive of abdominal TB with a
Medison SonoAce 9900 ultrasound machine (Seoul,
Korea) using a 7.5mHz convex probe and a 7.5 mHz lin-
ear probe. The presence of abdominal lymphadenopathy
was considered significant if there were more than three
lymph nodes or at least one lymph node 12 mm or more
in size. Lymph nodes were sought in the paraaortic re-
gion, the porta hepatis region, the mesentery and the
splenic hilum. The role of abdominal ultrasound in diag-
nosis of extrapulmonary or disseminated TB was previ-
ously evaluated, and a significant correlation was found
between abdominal lymphadenopathy and active TB as
diagnosed by smear or culture [23], thus abdominal
ultrasound was found valuable in diagnosing EPTB [24].
Chest x-ray was performed with patients in standing pos-
ture and holding their breath, using a Schimadzu machine
(Shimadzu-Japan), with the patient’s chest positioned
150 cm away from the x-ray tube. The chest X-ray was con-
sidered abnormal when it showed any of the following:
lobar/segmental consolidation, cavitation, fibronodular le-
sions, pleural effusion, hilar and mediastinal lymph nodes,
linear interstitial disease or miliary disease.Fine needle aspiration (FNA)
FNA was performed on consenting participants fulfilling in-
clusion criteria. Under aseptic conditions, the lymph node
was immobilized with left hand to entirely access it while
the right hand was used to aspirate. Using a 23G cutting
needle and a 2 ml syringe lymph node aspiration was done
with constant suction in a fan like fashion until the material
appeared in the hub. The suction was then released, the
needle withdrawn and the patient was asked to apply pres-
sure to the punctured wound to prevent bleeding. Lymph
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mycobacteria.
Cytomorphology
Aspirated lymph node material was expressed on to a
glass slide with 3 ml of syringe air. The material was
gently spread on the second slide by pulling the two
slides facing each other gently apart. For each aspirate
four slides were prepared, one for Papanicolaou stain,
two for acid fast bacilli (AFB) stain (Ziehl Neelsen and
fluorochrome respectively) while one was air dried for
Romanowski stain (Biostains, UK) using standard proto-
cols [25,26]. Cytomorphological findings were recorded
in terms of presence or absence of granuloma formation,
necrosis, Langhans giant cells and epitheloid trans-
formed macrophages [27].
Identification of the Uganda genotype strains
Sample processing for culture
Five ml of lymph node aspirate in distilled water was ho-
mogenized by digestion and decontaminated using the
standard N-acetyl-L-cysteine (NALC)-Sodium hydrox-
ide/Sodium citrate method [28] and the resulting sedi-
ment used for making smears and cultures on solid
Lowenstein Jensen medium and the BACTEC MGIT
960 (Becton Dickinson Diagnostic Systems, Sparks, Md).
Positive cultures were subjected to AFB staining for con-
firmation of mycobacterial growth.
DNA was extracted from growth using standard proto-
cols [29,30] (Reagents from Sigma life Science, USA).
Capilia TB assay (TAUN, Numazu, Japan), based on lat-
eral flow immunochromatographic detection of a protein
which is highly specific for MTB complex(MPB64) was
used to differentiate M. tuberculosis complex isolates
from non-tuberculous mycobacteria [31].
Spoligotyping
All M. tuberculosis complex strains were assayed by spo-
ligotyping using standard protocols [32] (reagents from
Ocimum Biosolution). Isolates were assigned specific
spoligotype signatures (SIT) according to SITVITWEB
database [33], which were used to determine their spe-
cific genotypes. The T2 lineage, to which the Uganda
genotype belongs was identified. T2 lineage strains are
characterized by a spoligotype pattern lacking spacers
40, or both 40 and 43 as previously described [34].
Region of difference (RD) analysis
This PCR based M. tuberculosis complex typing method
depends on chromosomal region of difference (RD) dele-
tion loci. The patterns of amplification products are visual-
ized by agarose gel electrophoresis. All isolates were
analyzed for a deletion at the RD724 locus, which is specific
for the Uganda genotype as previously described [14].For statistical analyses, genotypes were grouped into
two: Uganda genotype (T2 strains with a deletion at the
RD724 locus) and non-Uganda genotype (all other strain
types in the collection).
Statistical analyses
Clinical and socio-demographic data earlier collected were
entered into Epidata v 3.1 and exported to SPSS v21.
Descriptive analysis was used for the baseline charac-
teristics. Pearson chi square was used to measure differ-
ences between the two M. tuberculosis genotype
categories with respect to demographic parameters. The
independent t-test was used to compare the means of
the continuous variables, age and lymph node size.
Crude and multivariable logistic regression analysis was
used to explore clinical, radiological and pathological
features of the Uganda genotype compared with non-
Uganda genotypes of M. tuberculosis controlling for po-
tential confounding factors including sex, age and HIV
status. Odds ratios (ORs) with corresponding 95% confi-
dence intervals (CI) were calculated and are presented.
A P value of <0.05 was considered evidence of signifi-
cant difference.
Results
Of the 283 patients with superficial lymphadenopathy
and clinical features of TB and with cytological features
consistent with tuberculous lymphadenitis enrolled, 121
(43%) had lymph node aspirates that turned out culture
positive for M. tuberculosis complex, of which 55 (45%)
were also ZN smear positive. 29 (53%) of these were
Uganda genotype. Three (1.8%) samples were positive
for non-tuberculous mycobacteria, while 159 (56%)
turned out culture negative and were all excluded from
further analysis.
Patient characteristics
Of the 121 patients with tuberculous lymphadenitis 62
(52%) were female and 58 (48%) male, mean age being
28.5 years (range 2–61 years) (Table 1). The gender of
one patient was not recorded. Of 114 patients who con-
sented to HIV testing 75 (66%) were HIV positive while
39 (34%) were HIV negative. Seven patients did not con-
sent to HIV testing. The major clinical signs were: a his-
tory of evening fever (all patients), night sweats (n = 98,
81%) and cough (n = 57, 47%). Sixty-six (55%) patients
presented with lymphadenitis at a single site, and of
those 25 (38%) had no signs of pulmonary and/or ab-
dominal disease. Seventy-five (62%) patients were found
to have pulmonary and/or abdominal involvement in
addition to superficial lymphadenopathy.
The lymph node site distribution among the patients
were as follows: right posterior cervical triangle 21
(17.4%), right anterior cervical triangle 10 (8.3%), left
Table 1 Baseline characteristics of patients infected with
Uganda and non-Uganda strains
Uganda genotype
n = 56 (46%)
Non-Uganda genotype
n = 65 (54%)
P-Value
HIV Status
HIV + 31 (61%) 44 (70%) 0.311
HIV - 20 (39%) 19 (30%)
Age
Mean 27 (SD 10) 30 (SD 11) 0.225
Sex:
Female 30 (55%) 32 (49%) 0.562
Male 25 (45%) 33 (51%)
Chi-square and t-test.
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vical triangle 3 (2.5%), left supra clavicular 2 (1.7%), right
supra clavicular 1 (0.8%), left axillary 1 (0.8%), general-
ized superficial lymphadenopathy 16 (13.2%) and bilat-
eral cervical lymphadenopathy 39 (32.2%).
The mean lymph node sizes calculated using the inde-
pendent samples t- test model were 3.8 cm (standard de-
viation, SD 1.8) for patients infected with non-Uganda
genotypes and 3.4 cm (SD 2.0) for patients infected with
Uganda genotype (p = 0.305).
Cytomorphological features
In practically all FNA samples (n = 113) there was necro-
sis (amorphous, caseous or suppurative). Granuloma
were found in 93 (77%), Langhans giant cells in 53 (44%)
and macrophages in 111 (92%) cases (Figure 1).
Abdominal ultrasound
Sixty patients had abdominal lymphadenopathy, ie more
than three lymph nodes, or at least one lymph node of
more than 12 mm in size. The involved anatomic sites
included the para-aortic region, the porta hepatis region,
the mesentery and the splenic hilum.
Chest X-ray
Forty-seven patients had an abnormal chest X-ray, with
6 having lobar/segmental consolidation, 2 cavitation, 4
fibronodular lesions, 7 pleural effusion, 12 hilar and me-
diastinal lymph nodes, 7 linear interstitial disease, and 9
miliary disease.
M. tuberculosis complex genotypes
Spoligotyping revealed 54 distinct spoligotype patterns,
of which 33 (61%) patterns were available in the SITVIT-
WEB and 21 (39%) patterns were not found in the data
base. Spoligotypes representing the Euro American
lineage (to which the Uganda genotype belongs) were
predominant (62%), followed by the Central Asian Strain(CAS) lineage (18%). There were three Beijing strains
and no Mycobacterium bovis.
On characterization by spoligotyping and RD724 dele-
tion analysis, the 121M. tuberculosis complex isolates
yielded 56 (46%) isolates of the Uganda genotype while
65 (54%) were non- Uganda genotypes.
Association between patient characteristics and Uganda
genotype
There were no statistically significant differences be-
tween patients infected with Uganda genotype and pa-
tients infected with non-Uganda genotypes with respect
to the baseline parameters age, sex and HIV status
(Table 1).
To investigate if there were differences in clinico-
pathological characteristics of the tuberculous lymph-
adenitis patients infected with Uganda genotype versus
those infected with other genotypes, we assessed the
clinical, radiological and pathological features of patients
in the two groups (Table 2). Since the disease outcome
following infection with M. tuberculosis may be influ-
enced by confounding factors like age, sex and HIV,
multivariable logistic regression was used with M. tuber-
culosis genotype, age, sex and HIV status entered into
the model to adjust for these confounding variables.
There were no statistically significant differences be-
tween the two groups (Uganda versus non-Uganda) with
respect to cough, fever duration (more or less than
6 months), night sweats, lymph node size, and chest X
ray findings (Table 3). However, patients infected with
Uganda strains were significantly less prone to have ab-
dominal lymphadenopathy compared to those infected
with non-Uganda strains (OR 0.4, 95%CI 0.2-0.4,
p = 0.014), even after adjusting for HIV infection, age
and sex (OR = 0.5,95% CI 0.2-1.0,P = 0.046). Of the 16
patients with generalized lymphadenopathy 5 (31%) were
infected with Uganda genotype strains while 11 (69%)
were infected with non-Uganda genotypes.
Association of abdominal lymph node enlargement with
features indicative of TB severity or dissemination
Abdominal lymph node enlargement was significantly asso-
ciated with abnormal chest X-ray findings (p = 0.027),
There was no statistically significant association between
abdominal lymph node enlargement and generalized
lymphadenopathy, AFB smear positivity or absence of
granulomas (Table 4).
Discussion
In this cross-sectional study of patients presenting with
tuberculous lymphadenitis and clinical signs of TB we
found a high prevalence of infection at other sites, with
9 patients with miliary pulmonary TB at the extreme
end of the disease spectrum, while only 38% of the
Figure 1 Cytomorphological features of tuberculous
lymphadenitis. (A) Tuberculous lymphadenitis with chronic
granulomatous inflammation comprising epitheloid cells,
lymphocytes, multinucleated giant cells and caseous necrosis.
(B) Tuberculous lymphadenitis with amorphous necrosis containing
a few lymphocytes. (C) Tuberculous lymphadenitis with suppurative
necrosis and a number of AFBs.
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pulmonary engagement.
Lymphadenopathy (superficial as well as systemic, in-
cluding abdominal lymphadenopathy) is regarded as a
manifestation of EPTB, where the mode of infection in-
cludes haematogenous spread from a primary focus or
in miliary TB, lymphatic spread from infected lymph
nodes, ingestion of bacilli and direct spread from adja-
cent viscera [35]. There are indications that the homeo-
static immune response in tuberculous lymphadenitis is
fundamentally different from that of pulmonary TB [36].
Tuberculous lymphadenitis patients infected with
Uganda genotype strains were significantly less prone to
present with abdominal lymphadenopathy (p = 0.014)
than those patients infected with non-Uganda strains,
even after adjusting for confounding factors including
age, sex and HIV co-infection (p = 0.046). Abdominal
lymph node enlargement was itself significantly associ-
ated with abnormal chest X-ray findings (p = 0.027), one
of the features indicative of TB severity or dissemination.
Interestingly, the Uganda genotype which is responsible
for close to 70% of pulmonary TB disease in our setting
[14], in this study caused only 46% of the 121 cases of
tuberculous lymphadenitis. Tuberculous lymphadenitis
is the commonest form of extra pulmonary TB in high en-
demic areas [18,37]. Previous evidence also suggest that
strains of the Euro-American lineage of M. tuberculosis to
which M. tuberculosis Uganda genotype belongs less fre-
quently cause EPTB [11,12].
Thus the Uganda genotype appears to have a reduced po-
tential to disseminate and cause extra-pulmonary disease,
and may inversely have a higher potential to cause pulmon-
ary TB. Since pulmonary TB is more contagious than EPTB
the Uganda genotype may have an advantage in transmis-
sion of TB which is reflected in the high incidence of this
genotype in Uganda and surrounding areas [38]. The dom-
inance of the Uganda genotype has however not been asso-
ciated with pulmonary cavitation [39], which is associated
with tissue liquafactive necrosis and cough generated aero-
sol, an efficient mechanism by which TB is spread.
A particular strain of Uganda genotype (SIT52) caused a
large outbreak of TB in Sweden [40]. This strain exhibited
extensive cell death of macrophages infected in vitro, with
production of elevated amounts of tumor necrosis factor
(TNF) compared to the virulent laboratory H37Rv strain
[41]. The interplay of TNF and other cytokines in the early
innate immune response is complex, but it is noteworthy
that TNF neutralization in animal models including non-
human primates resulted in disseminated disease in M. tu-
berculosis infected animals [42].
Risk factors for extra pulmonary TB include age, sex
and HIV co-infection [21,43,44]. Not unexpectedly a
high proportion (66%) of the patients in this study were
HIV-infected, a figure which is similar to studies of
Table 2 Clinical and immunopathological parameters of patients infected with Uganda genotype and those infected




OR (95% CI) P-value OR (95% CI) P-value
Clinical presentations
Fever less than 6 months 39 (70%)/44 (69%) 1.0 (0.5-2.3) 0.916 1.1 (0.5-2.5) 0.870
Night sweats 43 (77%)/55 (86%) 0.5 (0.2-1.4) 0.200 0.5 (0.2-1.4) 0.213
Cough 27 (48%)/30 (46%) 1.1 (0.5-2.2) 0.821 1.4 (0.7-3.1) 0.435
Radiological Presentations
Abnormal Chest X-ray 20 (43%)/27 (47%) 0.8 (0.4-1.8) 0.624 0.8 (0.4-1.9) 0.644
Abdominal lymphadenopathy 21 (38%)/39 (60%) 0.4 (0.2-0.8) 0.014 0.5 (0.2-1.0) 0.046
Lymph node Pathology
Single site lymphadenitis 34 (62%)/32 (50%) 1.6 (0.8-3.4) 0.197 1.4 (0.6-2.9) 0.435
Generalized lymphadenopathy 5 (9%)/11 (17%) 0.5 (0.2-1.5) 0.204 0.7 (0.2-2.1) 0.474
Lymph node≥ 4 cm 15 (28%)/28 (45%) 0.5 (0.2-1.0) 0.055 0.6 (0.3-1.3) 0.157
Necrosis 52 (93%)/61 (94%) 0.9 (0.2-3.6) 0.827 0.8 (0.2-3.4) 0.741
Giant cells 28 (50%)/25 (38%) 1.6 (0.8-3.3) 0.203 1.3 (0.6-2.8) 0.569
Macrophages 53 (95%)/58 (89%) 2.1 (0.5-8.7) 0.290 1.5 (0.4-6.9) 0.577
Granulomas 47 (84%)/46 (71%) 2.2 (0.9-5.3) 0.091 1.9 (0.8-4.8) 0.196
Ziehl Neelsen positive smear 29 (52%)/42 (65%) 0.6 (0.3-1.2) 0.152 0.7 (0.3-1.5) 0.348
Adjusted* = Adjusted for Age, Sex and HIV status; OR = Odds ratio, Cl = Confidence Interval.
Logistic regression.
Table 4 Association of abdominal lymph node
enlargement with features indicative of TB dissemination
(i.e. generalized lymphadenopathy, abnormal chest
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African countries [45,46]. It is well known that HIV co-
infection represents an increased risk of dissemination
of TB involving multiple organs, through several im-
munological mechanisms not yet quite well understood
[47], and infection with HIV increases the incidence and
severity of abdominal TB [37]. Thus 7 patients with mil-
iary TB were HIV-infected while the sero status of the
remaining 2 patients was not known. However, HIV-
status did not affect the proportion of patients infected
with Uganda genotype, and only marginally affected the
negative correlation between Uganda genotype and abdominalTable 3 Distribution of the chest abnormalities among








Lobar/segmental consolidation 6 (12.8%) 5 (83%) 1 (17%)
Cavitation 2 (4.3%) 0 (0%) 2 (100%)
Fibro nodular lesions 4 (8.5%) 2 (50%) 2 (50%)
Pleural effusion 7 (14.9%) 2 (29%) 5 (71%)




5 (42%) 7 (58%)
Linear interstitial disease 7 (14.9%) 1 (14%) 6 (86%)
Miliary disease* 9* (19.1%) 5 (56%) 4 (44%)
*7 patients are HIV positive, while the remaining 2 patients’ sero-status
was unknown.lymphadenitis, indicating that HIV-status was not im-
portant for the differences in clinical manifestations be-
tween Uganda and non-Uganda genotypes.
The indication of a lower tendency to form extrapul-
monary disease by the Uganda genotype compared withn = 60 (49.6%) n = 61 (50.4%)
Generalized lymphadenopathy:
Present 30 (57%) 23 (43%) 0.170
Absent 20 (39%) 19 (30%)
Granuloma:
Present 46 (50%) 47 (50%) 0.960
Absent 14 (50%) 14(50%)
Abnormal findings on Chest X-ray:
Present 30 (64%) 17 (36%) 0.027
Absent 24 (41%) 34 (59%)
AFB smear positivity: (Ziehl Neelsen or fluorochrome stain)
Positive 39 (65%) 29 (47%) 0.053
Negative 21 (35%) 32 (53%)
Chi-square test.
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of TB cases that showed a relationship between phylo-
genetic lineage and clinical site (pulmonary versus extra
pulmonary) of TB [48]. In a study from Vietnam disease
caused by the Euro-American lineage was significantly
more likely to be pulmonary than meningeal, which sug-
gests that this lineage is less capable of extrapulmonary
dissemination in this population [49].
Extrapulmonary disease has been associated with the
East Asian/Beijing genotype [50]. Patients infected with
strains of Beijing genotype were found to have significantly
lower frequency of fever and pulmonary cavitation than
those infected with other genotypes of M. tuberculosis
[51], and were associated with characteristic radiological
patterns [52]. These associations seem to hold for some
populations and not for others [53,54], and may be
explained by the fact that the Beijing lineage has
evolved into distinct branches defined by specific RD
deletions [55] with different impact on the immune re-
sponse [56]. On the other hand there was no difference
in lineage distribution between cases of pulmonary and
extrapulmonary TB in a study from Ethiopia [57], a
country with a high incidence of tuberculous cervical
lymphadenitis [57], and a study from South Africa [58]
found no significant relationship between mycobacterial
genotype and EPTB. Yet, it is increasingly evident that
the genetic diversity of M. tuberculosis strains contrib-
utes to the wide clinical spectrum of TB [59,60].
The limitation of this study is the fact that unlike
animal models, the patients live in a heterogeneous
socio-economic environment which may confer varying
susceptibility and resistance to TB. Factors like clinical
stages of TB and/or HIV and immunosuppressive states
like malnutrition and diabetes mellitus may contribute
to disease outcome in TB patients.
Conclusion
In summary, tuberculous lymphadenitis patients infected
with strains of Uganda genotype were significantly less
prone to have abdominal lymphadenopathy and may be
less susceptible to developing severe or disseminated
TB. The frequency of Uganda genotype in this study was
lower than the frequency of Uganda genotype reported
for pulmonary TB in the same setting. Genotyping of M.
tuberculosis may aid clinicians make better therapeutic
decisions and predict patient prognosis.
Further studies are indicated to elucidate the clinical-
pathological significance of the genetic diversity of
M. tuberculosis strains and lineages in Uganda for un-
derstanding the outcome of infection with the Uganda
genotype.
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